Fasting the month of Ramacfan is a unique metabolic exercise which has not been studied properly. We have carried out the first red cell survival study during Rarnacfiin fasting. The subjects were six normal adults and three adult patients with sickle cell disease. All the subjects fasted the whole month. The ranges of 51 CrT50 for normal subjects and patients were 25-40 and 10-12.5 days respectively. These are similar to the published values for non-fasting subjects. We did not note any harm/ ul effects from Ramacfan fasting on the red cell survival in our subjects to j ustify giving advice against fasting.
Introduction
Fasting the month of Rama9an is obligaLory for all adult Muslims, as it is one of the five PiJlars of Islam.
"Ye who believe! Fasting is prescribed to you as it was prescribed to those before you, that ye may Oearn) self-restraint. ' AJI adult Muslims fast every year from dawn until sunset during the month of Rama9an, which varies from 29 to 30 days. During the fasting hours, Muslims refrain from eating, drinking and smoking, and maintain sexual continence. AL night, none of the above things are prohibited. However, if a person is ill, or if fasting produces a deleterious effect on their health, they are exempt from fasting.
"But if any of you is ill, or on a journey, the prescribed number (should be made up) from days later. 2 This has lo be determined by the person's own experience and by advice from a doctor.
Few reports have described biochemical and endocrine changes in bloodJ-1 and fluid and electrolyte balance' during Rama9an fasting. In one study' 0 it was claimed that there may be a decrease in the mean red cell survival time as a result of Rama9an fasting. This was based on the observation of a rise in the mean cell volume and a non-significant rise in the serum iron, although the hemoglobin and the hematocrit were higher during Rama9an than the levels were beforehand. Our study was designed to verify this, and to discover whether Rama9an fasting has any deleterious effects on hematological values, including red cell survival, in normal subjects as well as sickle cell anemia patients. To our knowledge, this is the first study of red cell survival during Rama9an fasting.
Methods and subjects
Nine adult subjects participated in this study including three healthy males, three healthy females and three patients with sickle cell anemia (two females, one male). The range of the ages was 20 to 45 years.
Females were selected based on menstrual cycle such that none had a menstrual period during the time of the red cell survival study (15 days). All subjects maintained the Muslim fasting during DOI: http://dx.doi.org/10.5915/22-1-13520 Rama<;lan. Average fasting time was about 15 hours. The sickle cell anemia patients had been followed for some time in our hospital. Diagnosis in each was confirmed by family studies after finding hemolytic anemia and a single major band at HbS position on electrophoresis. Blood for complete blood count (CBC) was collected in disposable sequestrine bottles. CBC was done in a Coulter Counter Model S + IJ . ReticuJocyte count was done using standard techniques. 11 All investigations were done immediately before the month of Rama<;lan, then repeated on days 10, 19 and 25 of thal month.
Red Cell Survival Studies
In order to allow time for the effects of the fasting, red cell survival studies begun on day JO of Rama<;lan. The method used is based on that recommended by the International Committee for Standardization in Haematology, 12 with slight modification to suit our study. Ten milliliters of blood were drawn and added to 1 .5 ml of acid citrate dexlrose (ACD) solution in a sterile bottle. After centrifugation and removal of most of the plasma, 50 UCi of radioactive Sodium Chromate (5 I Cr) were added and the contents incubated at 37 ° C for 30 minutes. The red cells were then washed twice in sterile saline, after which 10 ml were slowly administered to the subject intravenously. One milliliter of the remaining red cells was diluted to 100 ml in distilled water, for use as a standard. Five milliliters of blood were drawn from a vein in the opposite arm 30 minutes after re-injecting the red cells (day JO). Subjects were then bled after 24 hours (day 1). Three specimens were collected between day 2 and day 7, and then every third day up to day 15 of the study (day 25 of Rama<;lan).
Although this covered the disappearance of 500/o radioactivity in sickle cell patients, il was unfortunately not possible to attain the same with normal controls due to the advent of Ramac;tan holidays, four days before the end of fasting. All samples were kept frozen al -30 °C. Each set of samples was then thawed and counted on the same day in a Beckmann 4 Alpha Counter. The radioactivity of the day 0 samples was taken as JOO% and subsequem counts calculated as a percentage of that. Results were plotted on semilogrithmic graph paper; the line extrapolated and 5 I CrT50 were taken as the time when 50% radioactivity had disappeared.
Results
All subjects completed the fasting of Rama<;lan without any significant complications. One female sickle cell patient had marked low back pain on day 14 of fasting. The male patient had pain in the left hip and ankles on day 15 of fasting. No significant changes were noted in the reticulocyte count, MCV, MCH or MCHC. The results are summarized in Table I .
Discussion
This study has shown thal there were no significant ill effects on our fasting subjects. In particular, none JIMA: Volume 22, 1990 -Page 5 of the sickle cell parients had to break their fasting. The range of 51CrT50 for our normal subjects during Ramac;tan was 25-40 days, which fits with the normal value in non-fasting normal subjects. 1 ' The range for sickle cell patients was 10-12.5 days. This lies within the expected range for non-fasting sickle cell patients which is quoted as 8-12 days.•> These results show that there is no reduction in red cell survival during Rama<;ian fasting.
The case of the male sickle cell fiatient is worth discussing in detail. Although his 1crT50 was 11 days, his hemoglobin dropped from 8.7 g/ dl before Rama<;ian to 7.5 g/dl on day 25 of the month. His reticulocyte count was 40Jo and 4.50Jo on those two days, respectively. His hemoglobin on day 19 of Rama<;ian was 8.6 g/dl and the reticulocyte count was 4.50Jo. The pain he experienced on day 15 of fasting was associated neither with fever nor with an increase in the intensity of jaundice or reticulocyte count. However, we could not exclude a mild aplastic reaction of the bone marrow as a cause for the later drop in hemoglobin, especially as the reticulocyte count during the time did not rise.
Although we could not document any signi ficant deleterious effect of fasting in our normal subjects, more studies on large numbers of patients are needed before proper advice can be given to patients during Ramac;lan. Meanwhile, every case has to be assessed individually and, if the patient experiences any significant morbidity, he should be exempted from fasting.
